The Defiance S&P 500 Target Income ETF (SPYT) targets a high 20% annual dividend yield by selling daily call spreads on the S&P 500, generating income from option premiums. However, this strategy caps upside gains, causing SPYT to underperform the plain S&P 500 ETF (IVV), which returned 15.17% over the past year compared to SPYT's 11.52%. The fund works best in sideways, volatile markets but risks NAV erosion in strong rallies and does not protect against downturns. Investors seeking steady income with limited growth may find SPYT suitable, but those prioritizing total returns should note the tradeoff and competition from other funds and risk-free bonds.
The phase III ENDURANCE trial showed that two years of lenalidomide maintenance therapy offers the same long-term survival benefit as indefinite treatment for patients with standard-risk multiple myeloma who are not transplant candidates. After nearl...
Lowey Dannenberg, P.C. is investigating Hims & Hers Health, Inc. for allegedly sharing sensitive user health data, including medical histories and mental health info, with third parties without proper consent. This raises concerns about violations of...
Digital agency 9thCO completed a major digital transformation for DNRS, moving from a fragmented WordPress setup to a unified composable architecture. This upgrade centralizes user management, integrates key business tools like CRM and scheduling, an...
Willis Towers Watson, a global advisory firm, is poised for growth with a 25.3% potential stock upside, driven by new initiatives like KwantSure, a digital insurance sales channel for subcontractors, and a Geospatial Mortality Model to improve pensio...
AngioDynamics reported an 8% revenue increase to $86.6 million in Q4, driven by a 16.7% sales rise in its Med Tech division, notably from NanoKnife and AlphaVac products. H.C. Wainwright raised the price target from $16 to $19 and maintained a Buy ra...
